Navigation Links
Investigational Studies Highlight Potential Utility of Zevalin(R) (Ibritumomab Tiuxetan) Radioimmunotherapy in Stem Cell Transplantation for Non-Hodgkin's Lymphoma
Date:6/1/2008

pport. The maximum tolerated dose (MTD) was not reached in the study. These data indicate that the dose of (90)Yttrium used with the Zevalin regimen can be escalated provided there is a stem cell rescue.

(90)Yttrium Ibritumomab Tiuxetan Combined with High-dose BEAM Chemotherapy and Autologous Stem Cell Transplantation for Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma, Abstract 8615

The goal of this phase II trial was to evaluate the safety and efficacy of combining RIT with high-dose carmustine, cytarabine, etoposide, and melphalan (BEAM) chemotherapy and ASCT in patients with relapsed or refractory NHL. With a median follow up of 11 months, results from the first ten patients showed adverse events were similar to those seen with high-dose BEAM alone. The authors concluded that these preliminary results suggest that the combination of RIT and BEAM followed by ASCT is does not add significantly to the toxicity of BEAM alone and the combination is effective therapy.

About Zevalin(R)

Zevalin(R) (Ibritumomab Tiuxetan) is a form of cancer therapy called radioimmunotherapy and is indicated as part of the Zevalin therapeutic regimen for treatment of relapsed or refractory, low-grade or follicular B-cell non-Hodgkin's lymphoma, including patients with rituximab refractory follicular NHL. It was approved by the FDA in February of 2002 as the first radioimmunotherapeutic agent for the treatment of NHL.

Rare deaths associated with an infusion reaction symptom complex have occurred within 24 hours of rituximab infusions. Yttrium-90 Zevalin administration results in severe and prolonged cytopenias in most patients. Severe cutaneous and mucocutaneous reactions have been reported. The most serious adverse reactions of the Zevalin therapeutic regimen were primarily hematologic, including neutropenia, thrombocytopenia, and anemia. Infusion- related toxicities were associated with pre-administration of rituximab. The risk of hematologic toxicity
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Lexicon Presents Class of Compounds Modulating TPH1, the Target for its LX1031 Investigational Drug for Irritable Bowel Syndrome
2. FDA Grants Orphan Drug Designation to TREANDA, an Investigational Treatment for Chronic Lymphocytic Leukemia
3. Sanofi Pasteurs Investigational H5N1 Influenza Vaccine Achieves High Immune Response at low Dosage
4. Survival Data Presented From Phase II Study of Investigational Drug ZD4054 in Hormone-Resistant Prostate Cancer Patients
5. UCB Announces New Data Showing Investigational Drug Lacosamide Significantly Reduced Seizures in Refractory Epilepsy Patients
6. Lexicon Files Investigational New Drug Application for LX1032 as a Potential Treatment for Carcinoid Syndrome
7. New Drug Application for Tolvaptan, Otsukas Investigational Novel Oral Treatment for Worsening Heart Failure and Hyponatremia, Accepted by the U.S. Food and Drug Administration
8. Daiichi Sankyo, Lilly Submit New Drug Application for Investigational Antiplatelet Drug, Prasugrel, with U.S. Food and Drug Administration
9. Velcura Therapeutics, Inc. Can Begin Clinical Trials Following Successful Investigational New Drug Application to U.S. FDA
10. CHOP-Zevalin(R) Investigational Regimen Produces 95% Complete Remission and 75% Estimated Two Year Progression-Free Survival in Elderly Patients with Diffuse Large B-cell Lymphoma
11. AstraZeneca Completes Enrollment in Two Pivotal Phase III Studies of the Investigational Drug Vandetanib (ZACTIMA(R)) in Non-Small Cell Lung Cancer (NSCLC)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... D.C. (PRWEB) September 22, 2014 ... Georgetown President John DeGioia on Friday renewed their ... for an additional five years to expand the ... biosecurity, nonproliferation and global climate, energy and environmental ... of an MOU originally signed in December 2009 ...
(Date:9/22/2014)... (PRWEB) September 22, 2014 ... desire to stay young has groomed and nurtured ... industry worldwide. Growing emphasis on appearance maintenance is ... is a neurotoxic protein obtained from the bacterium, ... resulting in muscle relaxation. With cosmetic indications for ...
(Date:9/22/2014)... D.C (PRWEB) September 22, 2014 FierceBiotech ... top privately held biotechnology companies of 2014. FierceBiotech ... companies before selecting this year’s winners. Those selected ... biotechnology companies in the industry. , "It's ... new group of Fierce 15 companies," said Carroll. "This ...
(Date:9/22/2014)... -- Spherix Incorporated (SPEX) -- an intellectual property development company committed ... that the United States Patent & Trademark Office (USPTO) issued ... September that is part of a standard essential family of ... , Application number: US 13/728,867 , Publication date: ... The listed inventors of the new patent, ...
Breaking Biology Technology:Lawrence Livermore Renews Pact with Georgetown University to Expand Research and Education in Science and Policy 2Strong Demand for Non-Invasive Cosmetic Procedures Drives the Global Botulinum Toxin Market, According to New Report by Global Industry Analysts, Inc. 2Strong Demand for Non-Invasive Cosmetic Procedures Drives the Global Botulinum Toxin Market, According to New Report by Global Industry Analysts, Inc. 3FierceBiotech Announces Annual “Fierce 15” Winners of 2014 2Spherix Notified by United States Patent & Trademark Office of New Standard Essential Patent Issued to Spherix 2Spherix Notified by United States Patent & Trademark Office of New Standard Essential Patent Issued to Spherix 3
... Scientists at the U.S. Department of Energy,s Lawrence ... at Berkeley have created the world,s first all-integrated ... sensors and electronics made of different crystalline materials. ... such devices with high uniformity. , Nanostructures ...
... $24.7 million in Q2 2007 ... Q2 2008 Diluted Net Income per Share - $0.13 vs. $0.08 in Q2 2007 - ... increase of 62.5% ... Bookings of $49.0 million vs. $34.5 million in Q2 2007, PHILADELPHIA, Aug. 4 eResearchTechnology,Inc. (eRT), ...
... August 3-8, CHICAGO, Aug. 4 Criminal punishment ... reduce the spread of the virus.,Instead, it increases stigma ... women and other vulnerable groups who,are unable to disclose ... to a commentary in the August issue of the ...
Cached Biology Technology:A first in integrated nanowire sensor circuitry 2A first in integrated nanowire sensor circuitry 3A first in integrated nanowire sensor circuitry 4eResearchTechnology Reports Second Quarter 2008 Results 2eResearchTechnology Reports Second Quarter 2008 Results 3eResearchTechnology Reports Second Quarter 2008 Results 4eResearchTechnology Reports Second Quarter 2008 Results 5eResearchTechnology Reports Second Quarter 2008 Results 6eResearchTechnology Reports Second Quarter 2008 Results 7eResearchTechnology Reports Second Quarter 2008 Results 8eResearchTechnology Reports Second Quarter 2008 Results 9JAMA Commentary Opposes Criminal Punishment for HIV Exposure/Transmission 2JAMA Commentary Opposes Criminal Punishment for HIV Exposure/Transmission 3
(Date:9/22/2014)... (September 22, 2014) Additive manufacturing (AM), or ... the production of complex-shaped metal components strong enough ... fewer errors and distortions, as well as quality ... kept pace with the technology. Engineers at the ... proposing to develop enhanced modeling and simulation (M&S) ...
(Date:9/22/2014)... Due to global warming, larger and larger areas of sea ... freezes over in the winter it is thinner and more ... see an acceleration of global warming, because reduced sea ice ... Danish scientists report. , "If our results are representative, then ... should take this into account in future global CO2 budgets", ...
(Date:9/21/2014)... (SACRAMENTO, Calif.) Mothers of children with autism are significantly ... during their pregnancies than the mothers of children who ... UC Davis MIND Institute has found. , Low iron ... autism in the child if the mother was 35 ... or if she suffered from metabolic conditions such as ...
Breaking Biology News(10 mins):Pitt engineers receive grants to enhance additive manufacturing 2Pitt engineers receive grants to enhance additive manufacturing 3Arctic sea ice helps remove CO2 from the atmosphere 2Mothers of children with autism less likely to have taken iron supplements 2
... Two studies by researchers at UT Southwestern Medical Center could ... and strengthen current therapies for viral, bacterial, and parasitic infections. ... a sensor of innate immunity the body,s first line ... signaling pathway. This pathway detects foreign DNA or even host ...
... In our ongoing quest for alternative energy sources, researchers are ... use in biofuels, plants such as switchgrass. However, attempts ... make the plants more susceptible to any number of plant ... the American Association for the Advancement of Science, Michigan State ...
... February 2013)Scientists at the Nairobi-based World Agroforestry Centre (ICRAF) ... fire behavior, known as nomographs, for landscape managers in ... of the Journal of Arid Environments , pinpoints ... that when executed and timed properly, reduces the risk ...
Cached Biology News:UTSW researchers identify new enzyme that acts as innate immunity sensor 2Avoiding virus dangers in 'domesticating' wild plants for biofuel use 2Scientists develop improved fire management tools for Africa's savannas 2Scientists develop improved fire management tools for Africa's savannas 3
...
... Specificity: This antibody recognizes murine ... cross-react with other related IRF ... with murine IRF7 protein was ... of the 293T cells transfected ...
...
EMBP (FL-222)...
Biology Products: